trial · primary record
[177Lu]Lu-OncoFAP-23
FAP
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 56 |
| Primary completion | 2028-12-31 |
| Primary endpoint | Dose Limiting Toxicity |
| Registry ID | NCT06640413 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:47.270Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06640413
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.